HomeMarkets Markets Viking’s obesity drug study results are ‘almost flawless’, says Oppenheimer’s Jay Olson By news February 27, 2024 0 79 FacebookTwitterPinterestWhatsApp Jay Olson, Oppenheimer biotech analyst, joins ‘Fast Money’ to talk Viking’s best trading day ever and the results of its obesity drug study.This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,697FansLike396,312FollowersFollow2,310SubscribersSubscribe Latest Articles Markets Third day of bomb threats inspired by Trump lies sends Springfield hospitals into lockdown Markets Will the Far-Right Take Over Germany (Again)? Markets PhilStockWorld Weekly Market Wrap-Up: September 9-13, 2024 News Happy Weekend! Energy The Self-Inflicted Downfall of Mexican Energy Load more